Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
about
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.Heart failure with preserved ejection fraction: current status and challenges for the future.Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression.Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.
P2860
Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@ast
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@en
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@nl
type
label
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@ast
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@en
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@nl
prefLabel
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@ast
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@en
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@nl
P2093
P2860
P1476
Is enhancing cGMP-PKG signalli ...... h preserved ejection fraction?
@en
P2093
P2860
P2888
P304
P356
10.1007/S12471-016-0814-X
P407
P577
2016-04-01T00:00:00Z
P5875
P6179
1013223706